Citadel Advisors »

Aileron Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aileron Therapeutics (RNTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aileron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aileron Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aileron Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 28k 1.15
2025-06-30 $67k 48k 1.40
2024-03-31 $90k 14k 6.50

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Aileron Therapeutics

Voss Capital
BIOS Capital Management
Vanguard Group
Prosight Management
University of Texas Investment Management Company
Cable Car Capital
Sigma Planning
Geode Capital Management
Rima Management
Gagnon Securities
BlackRock
Northwestern Mutual Wealth Management Company
Chicago Partners Investment
Susquehanna International
Burns Wealth Management

View all funds holding Aileron Therapeutics